Background. Thrombotic thrombocytopenic purpura is an uncommon disease with a high
mortality rate even with current treatment. The cause of the syndrome and its optimal treatment …

In 1997, the Canadian Apheresis Group reviewed data on 103 416 plasma exchange
procedures that had been collected since 1980. Although the number of plasma exchanges …

The current established treatment of thrombotic thrombocytopenic purpura (TTP) is plasma
exchange with fresh frozen plasma (FFP). With this treatment, there is a 49% response after …

THE acceptance of the Renaissance concept that an illness could be helped by bloodletting
was tempered by the adverse effects of blood loss. Indeed, Louis XIII and George …

Objective: To determine the incidence and timing of relapses in patients who have recovered
from an acute episode of thrombotic thrombocytopenic purpura. Design: Clinical follow-up …

IN 1832, Elliotson described a patient with heart disease and "cold fits" who passed bloody
urine "whenever the east wind blew." Half a century later, Rosenbach described patients in …

Reactions of Non-Erythroid Cells with Cold Agglutinins Recently, it has been shown that cold
agglutinins react with Ii antigens on many types of normal and malignant cells in addition to …

Background: Plasma treatment has improved the outcomes in adults with thrombotic
thrombocytopenic purpura (TTP)—hemolytic uremic syndrome (HUS). We reviewed our experience …

Acute Guillain‐Barré syndrome is the most common cause of neuromuscular paralysis. Plasma
exchange and intravenous immune globulin (IV IgG) are both effective treatments for this …

Thrombotic thrombocytopenic purpura is an uncommon disorder that requires prompt recognition
and intervention to prevent death. To date, information regarding the classic laboratory …